Purple Biotech Reports Positive Final Results From Randomized Phase 2 Study of Cm24 in Second Line Pancreatic Cancer
purple biotech发布Cm24在二线胰腺癌随机第二阶段研究的积极最终结果
Purple Biotech Reports Positive Final Results From Randomized Phase 2 Study of Cm24 in Second Line Pancreatic Cancer
purple biotech发布Cm24在二线胰腺癌随机第二阶段研究的积极最终结果
使用浏览器的分享功能,分享给你的好友吧